Structural basis of androgen receptor binding to selective androgen response elements
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Steroid receptors bind as dimers to a degenerate set of response elements containing inverted repeats of a hexameric half-site separated by 3 bp of spacer (IR3). Naturally occurring selective androgen response elements have recently been identified that resemble direct repeats of the hexameric half-site (ADR3). The 3D crystal structure of the androgen receptor (AR) DNA-binding domain bound to a selective ADR3 reveals an unexpected head-to-head arrangement of the two protomers rather than the expected head-to-tail arrangement seen in nuclear receptors bound to response elements of similar geometry. Compared with the glucocorticoid receptor, the DNA-binding domain dimer interface of the AR has additional interactions that stabilize the AR dimer and increase the affinity for nonconsensus response elements. This increased interfacial stability compared with the other steroid receptors may account for the selective binding of AR to ADR3 response elements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The LBD and DBD X-ray crystal structures of AR have been solved separately (Matias et al., 2000; Sack et al., 2001; Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Shaffer et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“On one hand, the AR DBD forms a head-to-head dimer on DNA (Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Shaffer et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“Density for the two DBDs in all three models are consistent with the head-to-head conformation previously reported in the X-ray structure of the AR DBD dimer bound to non-palindromic ARE repeats”
From Allosteric interactions prime androgen receptor dimerization and activation (2022) · cites this paper as Shaffer et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Automated MAD and MIR structure solution
Terwilliger, T. C., & Berendzen, J. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444999000839 · Cited by 3,036
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., & Sigler, P. B. (1991) · Nature · doi:10.1038/352497a0 · Cited by 1,503
Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 808
Schwabe, J. W. R., Chapman, L., Finch, J. T., & Rhodes, D. (1993) · Cell · doi:10.1016/0092-8674(93)90390-c · Cited by 750
Structural determinants of nuclear receptor assembly on DNA direct repeats
Rastinejad, F., Perlmann, T., Evans, R. M., & Sigler, P. B. (1995) · Nature · doi:10.1038/375203a0 · Cited by 564
Research works printed but not linked: 6
- Rennie, P. S., Bruchovsky, N., Leco, K. J., Sheppard, P. C., McQueen, S. A., Cheng, H., Snoek, R., Hamel, A., Bock, M. E. & MacDonald, B. S. (1993) Mol. Endocrinol. 7, 23–36. [DOI] [PubMed] [Google Scholar]
- Verrijdt, G., Schoenmakers, E., Alen, P., Haelens, A., Peeters, B., Rombauts, W. & Claessens, F. (1999) Mol. Endocrinol. 13, 1558–1570. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- Nelson, C. C., Hendy, S. C., Shukin, R. J., Cheng, H., Bruchovsky, N., Koop, B. F. & Rennie, P. S. (1999) Mol. Endocrinol. 13, 2090–2107. [DOI] [PubMed] [Google Scholar] · doi:10.1210/mend.13.12.0396 · Paper page
- Lundberg Giwercman, Y., Nikoshkov, A., Lindsten, K., Bystrom, B., Pousette, A., Knudtzon, J., Alm, J. & Wedell, A. (2000) Horm. Res. 53, 83–88. [DOI] [PubMed] [Google Scholar]
- Kaspar, F., Klocker, H., Denninger, A. & Cato, A. C. (1993) Mol. Cell. Biol. 13, 7850–7858. [DOI] [PMC free article] [PubMed] [Google Scholar] · doi:10.1128/mcb.13.12.7850-7858.1993 · Paper page
- Schoenmakers, E., Alen, P., Verrijdt, G., Peeters, B., Verhoeven, G., Rombauts, W. & Claessens, F. (1999) Biochem. J. 341, 515–521. [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 101–200 of 414
Patki, M., Chari, V., Sivakumaran, S., Gonit, M., Trumbly, R. J., & Ratnam, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438473 · Cited by 76
Kim, J. H., Lee, J. M., Nam, H. J., Choi, H. J., Yang, J. W., Lee, J. S., Kim, M. H., Kim, S., Chung, C. H., Kim, K. I., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710343105 · Cited by 74
Constitutive Activity of the Androgen Receptor
Chan, S. C., & Dehm, S. M. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00011-0 · Cited by 71
Cao, Q., Song, Z., Ruan, H., Wang, C., Yang, X. W., Bao, L., Wang, K., Cheng, G., Xu, T., Xiao, W., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0396 · Cited by 61
The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
Zhu, R., Yang, G., Cao, Z., Shen, K., Zheng, L., Xiao, J., You, L., & Zhang, T. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920940946 · Cited by 63
46,XY disorders of sex development – the undermasculinised male with disorders of androgen action
Werner, R., Grötsch, H., & Hiort, O. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.002 · Cited by 65
Spinal and Bulbar Muscular Atrophy
Grunseich, C., & Fischbeck, K. H. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.002 · Cited by 58
Bhardwaj, A., Rao, M. K., Kaur, R., Buttigieg, M. R., & Wilkinson, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01170-07 · Cited by 58
Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium
Lim, M. A., Otto‐Duessel, M., He, M., Su, L., Nguyen, D., Chin, E., Alliston, T. N., & Jones, J. O. (2014) · ACS Chemical Biology · doi:10.1021/cb400759d · Cited by 58
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Huang, J., Lin, B., & Li, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.865350 · Cited by 62
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 56
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
Estébanez‐Perpiñá, E., Bevan, C. L., & McEwan, I. J. (2021) · Cancers · doi:10.3390/cancers13030509 · Cited by 57
Kumar, R., Atamna, H., Zakharov, M. N., Bhasin, S., Khan, S. H., & Jasuja, R. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.01.021 · Cited by 58
The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation
Kharraz, S. E., Dubois, V., van Royen, M. E., Houtsmuller, A. B., Pavlova, E., Atanassova, N. N., Nguyen, T., Voet, A. R. D., Eerlings, R., Handle, F., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152764 · Cited by 54
Self-citationDalal, K., Ban, F., Li, H., Morin, H., Roshan‐Moniri, M., Tam, K. J., Shepherd, A., Sharma, A., Peacock, J. W., Carlson, M. L., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.016 · Cited by 51
Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease
Arnold, F. J., & Merry, D. E. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00790-9 · Cited by 54
Allosteric interactions prime androgen receptor dimerization and activation
Wasmuth, E. V., Broeck, A. V., LaClair, J. R., Hoover, E. A., Lawrence, K. E., Paknejad, N., Pappas, K., Matthies, D., Wang, B., Feng, W., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.035 · Cited by 50
“Whether allosteric surfaces within the 3K-SR LBD contribute to DNA binding remains unclear as structural information has been limited to individual domains (He et al., 2004; Shaffer et al., 2004) or lacks structural features to unambiguously assign DNA or individual domains (Yu et al.”
BackgroundInfluentialTherapeutic Strategies to Target the Androgen Receptor
Xiang, W., & Wang, S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00716 · Cited by 51
Thiyagarajan, T., Ponnusamy, S., Hwang, D., He, Y., Asemota, S., Young, K. L., Johnson, D. L., Bocharova, V., Zhou, W., Jain, A. K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211832120 · Cited by 52
Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription
Bebermeier, J.-H., Brooks, J. D., DePrimo, S. E., Werner, R., Deppe, U., Demeter, J., Hiort, O., & Holterhus, P. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0081-1 · Cited by 54
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Parolia, A., Eyunni, S., Verma, B. K., Young, E., Liu, Y., Liu, L., George, J. M., Aras, S., Das, C. K., Mannan, R., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01893-6 · Cited by 47
Androgen receptor as a therapeutic target
Gao, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.002 · Cited by 53
Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers
Roshan‐Moniri, M., Hsing, M., Butler, M. S., Cherkasov, A. R., & Rennie, P. S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.10.005 · Cited by 49
Androgen insensitivity syndrome
Tadokoro‐Cuccaro, R., & Hughes, I. A. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000107 · Cited by 43
Targeting the Androgen Receptor with Steroid Conjugates
Levine, P. M., Garabedian, M. J., & Kirshenbaum, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500101h · Cited by 51
Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
Brand, L. J., & Dehm, S. M. (2013) · Current Drug Targets · doi:10.2174/1389450111314040005 · Cited by 44
Jin, Y., Duan, M., Wang, X., Kong, X., Zhou, W., Sun, H., Liu, H., Li, D., Yu, H., Li, Y., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00796 · Cited by 42
Androgen Receptor Regulates CD44 Expression in Bladder Cancer
Sottnik, J. L., Vanderlinden, L. A., Joshi, M., Chauca-Diaz, A., Owens, C. R., Hansel, D. E., Sempeck, C., Ghosh, D., & Theodorescu, D. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3095 · Cited by 43
Androgen Physiology: Receptor and Metabolic Disorders
McEwan, I. J., & Brinkmann, A. O. (2016) · Cited by 46
Marked Variation in Response of Consensus Binding Elements for the Rta Protein of Epstein-Barr Virus
Chen, L.-W., Chang, P., Delecluse, H., & Miller, G. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9635-9650.2005 · Cited by 42
The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response
Verrijdt, G., Tanner, T., Moehren, U., Callewaert, L., Haelens, A., & Claessens, F. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341089 · Cited by 39
Self-citationUnfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer
Monge, A., Jagła, M., Lapouge, G., Sasorith, S., Cruchant, M. D., Wurtz, J., Jacqmin, D., Jp, B., & Céraline, J. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5471-y · Cited by 46
Pantelireis, N., & Higgins, C. A. (2018) · Experimental Dermatology · doi:10.1111/exd.13690 · Cited by 42
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
Wadosky, K. M., & Koochekpour, S. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14090 · Cited by 44
Roggero, C. M., Jin, L., Cao, S., Sonavane, R., Kopplin, N. G., Ta, H. Q., Ekoue, D. N., Witwer, M., Ma, S., Liu, H., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01585-5 · Cited by 40
Zhang, L., Martini, G. D., Rube, H. T., Kribelbauer, J. F., Rastogi, C., FitzPatrick, V., Houtman, J. C. D., Bussemaker, H. J., & Pufall, M. A. (2017) · Genome Research · doi:10.1101/gr.222844.117 · Cited by 42
Fukuchi, S., Homma, K., Minezaki, Y., Gojobori, T., & Nishikawa, K. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-26 · Cited by 39
Physiology of Testicular Steroidogenesis
Stocco, D. M., & McPhaul, M. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50025-7 · Cited by 51
A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches
Bovee, T. F. H., Lommerse, J. P. M., Peijnenburg, A., Fernandes, E. C. A., & Nielen, M. W. F. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.035 · Cited by 39
Structural Basis of Natural Promoter Recognition by a Unique Nuclear Receptor, HNF4α
Lü, P., Rha, G. B., Melikishvili, M., Wu, G., Adkins, B. C., Fried, M. G., & Chi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806213200 · Cited by 43
Molecular underpinnings of enzalutamide resistance
Preković, S., den Broeck, T. V., Linder, S., van Royen, M. E., Houtsmuller, A. B., Handle, F., Joniau, S., Zwart, W. T., & Claessens, F. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0136 · Cited by 39
Self-citationD’Antonio, J. M., Griend, D. J. V., Antony, L., Ndikuyeze, G., Dalrymple, S. L., Koochekpour, S., & Isaacs, J. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011475 · Cited by 39
Li, B.-Y., Liao, X., Fujito, A., Thrasher, J. B., Shen, F.-Y., & Xu, P. (2007) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2007.00226.x · Cited by 40
Jankowski, A., Szczurek, E., Jauch, R., Tiuryn, J., & Prabhakar, S. (2013) · Genome Research · doi:10.1101/gr.154922.113 · Cited by 35
C/EBPα redirects androgen receptor signaling through a unique bimodal interaction
Zhang, J., Gonit, M., Salazar, M. D., Shatnawi, A. A., Shemshedini, L., Trumbly, R. J., & Ratnam, M. (2009) · Oncogene · doi:10.1038/onc.2009.373 · Cited by 39
Androgen Stimulates Transcription and Replication of Xenotropic Murine Leukemia Virus-Related Virus
Dong, B., & Silverman, R. H. (2009) · Journal of Virology · doi:10.1128/jvi.01763-09 · Cited by 37
A physiological role for androgen actions in the absence of androgen receptor DNA binding activity
Pang, T. P. S., Clarke, M. V., Ghasemzadeh, A., Lee, N. K. L., Davey, R. A., & MacLean, H. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.017 · Cited by 37
Androgen receptor splice variant 7 in castration‐resistant prostate cancer: Clinical considerations
Bryce, A. H., & Antonarakis, E. S. (2016) · International Journal of Urology · doi:10.1111/iju.13134 · Cited by 38
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Lamhamedi-Cherradi, S.-E., Maitituoheti, M., Menegaz, B. A., Krishnan, S., Vetter, A. M., Camacho, P. E., Wu, C.-C., Beird, H. C., Porter, R. W., Ingram, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30710-z · Cited by 37
Sakkiah, S., Ng, H. W., Tong, W., & Hong, H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1192131 · Cited by 36
Liu, C., Ma, J., Zhang, J., Zhao, H., Zhu, Y., Qi, J., Liu, L., Zhu, L., Jiang, Y., Tang, G., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00505 · Cited by 34
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
Asangani, I. A., Blair, I. A., Duyne, G. D. V., Hilser, V. J., Moiseenkova‐Bell, V. Y., Plymate, S. R., Sprenger, C. C. T., Wand, A. J., & Penning, T. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.012411 · Cited by 35
Dalal, K., Che, M., Que, N. S., Sharma, A., Yang, R., Lallous, N., Borgmann, H., Özistanbullu, D., Tse, R., Ban, F., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0259 · Cited by 33
Self-citationMarzouk, S. E., Gahattamaneni, R., Joshi, S. R., & Scovell, W. M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.034 · Cited by 37
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
Maeda, K., Habara, M., Kawaguchi, M., Matsumoto, H., Hanaki, S., Masaki, T., Sato, Y., Matsuyama, H., Kunieda, K., Nakagawa, H., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13030 · Cited by 32
Chaturvedi, A. P., & Dehm, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_15 · Cited by 37
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor
Radaeva, M., Ban, F., Zhang, F., Leblanc, E., Lallous, N., Rennie, P. S., Gleave, M. E., & Cherkasov, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052493 · Cited by 31
Jiménez‐Panizo, A., Pérez, P., Rojas, A. M., Fuentes‐Prior, P., & Estébanez‐Perpiñá, E. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0132 · Cited by 32
Molecular Characterization of Prostate Cancers in the Precision Medicine Era
Giunta, E. F., Annaratone, L., Bollito, E., Porpiglia, F., Cereda, M., Banna, G. L., Mosca, A., Marchiò, C., & Rescigno, P. (2021) · Cancers · doi:10.3390/cancers13194771 · Cited by 30
Gonit, M., Zhang, J., Salazar, M. D., Cui, H., Shatnawi, A. A., Trumbly, R. J., & Ratnam, M. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0409 · Cited by 34
Need, E. F., Scher, H. I., Peters, A. A., Moore, N. L. T., Cheong, A., Ryan, C. J., Wittert, G., Marshall, V. R., Tilley, W. D., & Buchanan, G. (2009) · Endocrinology · doi:10.1210/en.2008-1181 · Cited by 31
Horie‐Inoue, K., Bono, H. U., Okazaki, Y., & Inoue, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.174 · Cited by 29
New Opportunities for Targeting the Androgen Receptor in Prostate Cancer
Centenera, M. M., Selth, L. A., Ebrahimie, E., Butler, L. M., & Tilley, W. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030478 · Cited by 30
Orlova, N., Gerding, M. A., Ivashkiv, O., Olinares, P. D. B., Chait, B. T., Waldor, M. K., & Jeruzalmi, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1288 · Cited by 28
Sawant, M., Mahajan, K. N., Renganathan, A., Weimholt, C., Luo, J. R., Kukshal, V., Jez, J. M., Jeon, M. S., Zhang, B., Li, T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg4132 · Cited by 28
The androgen receptor messenger RNA: what do we know?
Likos, E., Bhattarai, A., Weyman, C. M., & Shukla, G. C. (2022) · RNA Biology · doi:10.1080/15476286.2022.2084839 · Cited by 32
A Molecular Analysis Provides Novel Insights into Androgen Receptor Signalling in Breast Cancer
Mehta, J., Asthana, S., Mandal, C. C., & Saxena, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120622 · Cited by 31
Androgen receptor complexes probe DNA for recognition sequences by short random interactions
van Royen, M. E., van Cappellen, W. A., Geverts, B., Schmidt, T., Houtsmuller, A. B., & Schaaf, M. J. M. (2014) · Journal of Cell Science · doi:10.1242/jcs.135228 · Cited by 31
Development, Molecular Biology, and Physiology of the Prostate
Berman, D. M., Rodríguez, R., & Veltri, R. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00090-6 · Cited by 39
Convergence of lipid homeostasis through liver X and thyroid hormone receptors
Berkenstam, A. L., Färnegårdh, M., & Gustafsson, J.-Α. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.05.005 · Cited by 30
Evolution of the androgen receptor: Perspectives from human health to dancing birds
Schuppe, E. R., Miles, M. C., & Fuxjager, M. J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110577 · Cited by 29
Small-Molecule Hormones: Molecular Mechanisms of Action
Puzianowska‐Kuźnicka, M., Pawlik-Pachucka, E., Owczarz, M., Budzińska, M., & Połosak, J. (2013) · International Journal of Endocrinology · doi:10.1155/2013/601246 · Cited by 30
Pippione, A. C., Boschi, D., Pors, K., Oliaro‐Bosso, S., & Lolli, M. L. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.44 · Cited by 35
Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer
Huang, F., Li, K., Shevach, J. W., & Wang, Q. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.04.004 · Cited by 29
Chukhu, M., Dahiya, U. R., & Heemers, H. V. (2025) · Oncogene · doi:10.1038/s41388-025-03573-z · Cited by 27
Kafka, M., Mayr, F., Temml, V., Möller, G., Adamski, J., Hoefer, J., Schwaiger, S., Heidegger, I. M., Matuszczak, B., Schuster, D., et al. (2020) · Cancers · doi:10.3390/cancers12082092 · Cited by 26
Xiao, F., Mirwald, A., Papaioannou, M., Baniahmad, A., & Klug, J. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0408 · Cited by 26
Advances in the computational development of androgen receptor antagonists
Hu, X., Chai, X., Wang, X., Duan, M., Pang, J., Fu, W., Li, D., & Hou, T. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.004 · Cited by 25
Targeting the N-terminal domain of the androgen receptor: The effective approach in therapy of CRPC
Ji, Y., Zhang, R., Han, X., & Zhou, J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115077 · Cited by 25
Barsky, S. T., & Monks, D. A. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00707-6 · Cited by 23
Pang, J., Shen, C., Zhou, W., Wang, Y., Shan, L., Chai, X., Shao, Y., Hu, X., Zhu, F., Zhu, D., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00632-5 · Cited by 25
Androgen Receptor Modulators: A Marriage of Chemistry and Biology
McEwan, I. J. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.69 · Cited by 25
Levine, P. M., Lee, E., Greenfield, A., Bonneau, R., Logan, S. K., Garabedian, M. J., & Kirshenbaum, K. (2012) · ACS Chemical Biology · doi:10.1021/cb300332w · Cited by 24
Malhotra, S., Alsulami, A. F., Heiyun, Y., Ochoa‐Montaño, B., Jubb, H. C., Forbes, S. A., & Blundell, T. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219935 · Cited by 23
The Effects of Dietary Supplements that Overactivate the Nrf2/ARE System
Smith, R. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190517113533 · Cited by 22
Sobhani, N., Generali, D., D’Angelo, A., Aieta, M., & Roviello, G. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0653-2 · Cited by 23
Chen, Y., & Lan, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451957 · Cited by 25
Splicing Factor Prp8 Interacts With NESAR and Regulates Androgen Receptor in Prostate Cancer Cells
Wang, D., Nguyen, M. M., Masoodi, K. Z., Singh, P., Jing, Y., O’Malley, K. J., Dar, J. A., Dhir, R., & Wang, Z. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1112 · Cited by 21
Azeem, W., Hellem, M. R., Olsen, J. R., Hua, Y., Marvyin, K., Qu, Y., Lin, B., Ke, X., Oyan, A. M., & Kalland, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177861 · Cited by 21
Rationale for the development of alternative forms of androgen deprivation therapy
Kumari, S., Senapati, D., & Heemers, H. V. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0121 · Cited by 21
AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0–3)
Wang, Y., Gong, C., Wang, X., & Qin, M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9084-9 · Cited by 21
Alegre‐Martí, A., Jiménez‐Panizo, A., Martínez-Tébar, A., Poulard, C., Peralta-Moreno, M. N., Abella, M., Antón, R. I., Chiñas, M., Eckhard, U., Piulats, J. M., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade2175 · Cited by 20
de Albuquerque, A. C. C., Bezerra, K. S., Vianna, J. F., Batista, S. D. O., Neto, J. X., Campos, D. M. D. O., Oliveira, J. I. N., Galvao, D. S., & Fulco, U. L. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01103 · Cited by 20
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner
Tam, K. J., Dalal, K., Hsing, M., Cheng, C. W., Khosravi, S., Yenki, P., Tse, C., Peacock, J. W., Sharma, A., Chiang, Y. T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14168 · Cited by 20
Androgen receptor and miR-206 regulation in prostate cancer
Chua, F. Y., & Adams, B. D. (2017) · Transcription · doi:10.1080/21541264.2017.1322668 · Cited by 20
Rosati, R., Polin, L., Ducker, C. E., Li, J., Bao, X., Selvakumar, D., Kim, S., Xhabija, B., Larsen, M. J., McFall, T. B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0982 · Cited by 21
Maffey, A. H., Ishibashi, T., He, C., Wang, X., White, A. R., Hendy, S. C., Nelson, C. C., Rennie, P. S., & Ausió, J. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.01.009 · Cited by 20
Chen, X., Chen, F., Ren, Y. T., Weng, G., Keng, P. C., Chen, Y., & Lee, S. O. (2019) · The Prostate · doi:10.1002/pros.23861 · Cited by 18
Identification and Characterization of Androgen Response Elements
Bruyn, R. D., Bollen, R., & Claessens, F. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-243-4_6 · Cited by 18
Self-citationRosati, R., Patki, M., Chari, V., Selvakumar, D., McFall, T. B., Saxton, J., Kidder, B. L., Shaw, P. E., & Ratnam, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745596 · Cited by 20
Metadata
- Authors
- Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T.
- Affiliations
- Duke Medical Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-03-22
- Volume
- 101
- Issue
- 14
- Pages
- 4758-4763
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC387321
- OpenAlex
- W2053535211
- Cited by
- 400
- References
- 47
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 19 · 2023: 20 · 2022: 30 · 2021: 20 · 2020: 17 · 2019: 24 · 2018: 17 · 2017: 26 · 2016: 13 · 2015: 16 · 2014: 21 · 2013: 26 · 2012: 13
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, DNA-binding domain, receptor dimerization, glucocorticoid receptor, crystal structure
- MeSH terms
- Androgens, Animals, Base Sequence, DNA, Models, Molecular, Mutation, Protein Binding, Protein Conformation, Receptors, Androgen, Dimerization, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.